Quanterix Corporation 13D and 13G filings for Akoya Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-16 6:00 pm Purchase | 2025-01-09 | 13D | Akoya Biosciences, Inc. AKYA | Quanterix Corp QTRX | 27,714,011 55.900% | 27,714,011 (New Position) | Filing |